Prenatal exposure to valproate was linked to increased odds of babies developing spina bifida and hypospadias, but researchers found that lowering the dose of the medication in the first trimester could control women's epileptic seizures without raising their child's risk of having the defects. The findings appear in the journal American Academy of Neurology.
Lowered valproate doses during pregnancy may curb birth defect risks
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|